You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site.


Go back

Our vaccines portfolio


Respiratory Syncytial Virus (RSV) vaccine (recombinant, adjuvanted)


Meningococcal group B vaccines (rDNA, component, adsorbed)


Diphtheria, tetanus and pertussis
(acellular, component) vaccine
(adsorbed, reduced antigen(s) content)

Engerix B 20mcg (Adult)

Hepatitis B (rDNA) vaccine (adsorbed) (HBV)


Hepatitis B (rDNA) vaccine (adjuvanted, adsorbed)

Havrix Monodose

Hepatitis A vaccine
(inactivated, adsorbed)

Havrix Junior Monodose

Hepatitis A vaccine
(inactivated, adsorbed)


Haemophilus Type b (Hib) vaccine

Infanrix Hexa

Diphtheria (D), tetanus (T),
pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type b (Hib) conjugate vaccine (adsorbed)


Haemophilus type b and Meningococcal group C conjugate vaccine


Meningococcal group C conjugate vaccine


Measles, Mumps and Rubella vaccine (live)


rotavirus vaccine, live


Herpes zoster vaccine (recombinant, adjuvanted)

Twinrix (Adult)

Hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed)

This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.

Adverse events should be reported directly to the Health Products Regulatory Authority (HPRA) on their website: Adverse events should also be reported to GlaxoSmithKline on 1800 244 255.

Arexvy, Bexsero, Boostrix, Engerix B, Fendrix, Havrix, Hiberix, Infanrix Hexa, Menitorix, Menjugate, Priorix, Rotarix, Shingrix and Twinrix are registered trademarks of the GlaxoSmithKline Group of Companies.